Alnylam Pharmace. buy SpringheelJack
Start price
08.05.20
/
50%
€130.98
Target price
08.07.20
-
Performance (%)
7.97%
End price
08.07.20
€141.42
Summary
This prediction ended on 08.07.20 with a price of €141.42. The BUY prediction by SpringheelJack finished with a performance of 7.97%. SpringheelJack has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.824% | -1.824% | 13.566% | 45.691% |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% | 49.791% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% | 96.632% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% | 69.047% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% | 68.087% |
Comments by SpringheelJack for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.